Evaluation of amoebicidal potential of paneth cell cryptdin-2 against entamoeba histolytica

PLoS Neglected Tropical Diseases

Volumn 5, Issue 12, 2011, Pages

  Preet, Simran ^a   Bharati, Sanjay ^a   Shukla, Geeta ^a   Koul, Ashwani ^a   Rishi, Praveen ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ANTIAMEBIC AGENT; CRYPTDIN 2; METRONIDAZOLE; N PHENYL NAPHTHYLAMINE; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; PROTEIN;

AMEBIASIS; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG SCREENING; ENTAMOEBA HISTOLYTICA; IN VITRO STUDY; IONIC STRENGTH; LC 50; MEMBRANE DAMAGE; MICROBIAL MORPHOLOGY; MINIMUM INHIBITORY CONCENTRATION; PANETH CELL; PHASE CONTRAST MICROSCOPY; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS; SCANNING ELECTRON MICROSCOPY; TROPHOZOITE; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG SENSITIVITY; HUMAN; ISOLATION AND PURIFICATION; MOUSE;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; ENTAMOEBA HISTOLYTICA; HUMANS; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, PHASE-CONTRAST; PANETH CELLS; PARASITIC SENSITIVITY TESTS; PROTEINS;

EID: 84855290535     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001386     Document Type: Article

References (44)

1. Lopez-Soto F, Leon-Sicairos N, Nazmi K, Bolscher JG, de la Garza M, (2010) Microbicidal effect of the lactoferrin peptides Lactoferricin 17-30, Lactoferrampin 265-284, and Lactoferrin chimera on the parasite Entamoeba histolytica. Biometals 23: 563-568.
2. World Health Organization (1997) Amoebiasis. WHO Weekly Epi Rec 72: 97-100.
3. Haque R, Roy S, Siddique A, Mondal U, Rahman SMM, et al. (2007) Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg 76: 713-717.
4. Mortimer L, Chadee K, (2010) The immunopathogenesis of E. histolytica. Exp Parasitol 126: 366-380.
5. Baxt LA, Singh U, (2008) New insights into Entamoeba histolytica pathogenesis. Curr Opin Infect Dis 21: 489-494.
6. Behnia M, Haghighi A, Komeylizadeh H, Tabaei SJS, Abadi A, (2008) Inhibitory effects of Iranian Thymus vulgaris extracts on in-vitro growth of Entamoeba histolytica. Korean J Parasitol 46: 153-156.
7. Upcroft JA, Campbell RW, Benakli K, Upcroft P, Vanelle P, (1999) Efficacy of new 5-nitroimidazoles against metronidazole- susceptible and-resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother 43: 73-76.
8. Upcroft P, Upcroft JA, (2001) Drugs targets mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14: 150-164.
9. Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P, (1997) Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother 40: 833-840.
10. Wassmann C, Hellberg A, Tannich A, Bruchhaus I, (1999) Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 274: 26051-26056.
11. Downey AS, Graczyk TK, Sullivan DJ, (2009) In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assay. J Antimicrob Chemother 64: 751-754.
12. Mor A, (2009) Multifunctional host defense peptides: antiparasitic activities. FEBS Journal 276: 6474-6482.
13. Tiana C, Gao B, Rodriguez MC, Lanz-Mendoza H, Ma B, et al. (2008) Gene expression, antiparasitic activity, and functional evolution of the drosomycin family. Molecular Immunology 45: 3909-3916.
14. Pascholati CP, Lopera EP, Pavinatto FJ, Caseli L, Nobre TM, (2009) The interaction of an antiparasitic peptide active against African sleeping sickness with cell membrane models. Colloids and Surfaces B: Biointerfaces 74: 504-510.
15. Wiesner J, Vilcinskas A, (2010) Antimicrobial peptides: The ancient arm of the human immune system. Virulence 1: 440-464.
16. Eisenhauer PB, Harwig SSSL, Lehrer RI, (1992) Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 60: 3556-3565.
17. Selested ME, Miller SI, Henschen AH, Ouellette AJ, (1992) Enteric defensins: antibiotic peptide components of intestinal host defence. J Cell Biol 118: 929-936.
18. Lencer WI, Cheung G, Strohmeier GR, Currie MG, Ouellette AJ, et al. (1997) Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci USA 94: 8585-8589.
19. Preet S, Verma I, Rishi P, (2010) Cryptdin-2: a novel therapeutic agent for experimental Salmonella typhimurium infection. J Antimicrob Chemother 65: 991-994.
20. Aley SB, Zimmerman M, Hetsko M, Selsted ME, Gillin FD, (1994) Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun 62: 5397-5403.
21. Inoue R, Tsuruta T, Nojima I, Nakayama K, Tsukahara T, et al. (2008) Postnatal changes in the expression of genes for cryptdins 1-6 and the role of luminal bacteria in cryptdin gene expression in mouse small intestine. FEMS Immunol Med Microbiol 52: 407-416.
22. Mastroianni JR, Ouellette AJ, (2009) α-defensins in enteric innate immunity: functional Paneth cell α-defensins in mouse colonic lumen. J Biol Chem 284: 27848-27856.
23. Tanabe H, Ouellette AJ, Cocco MJ, Robinson WE, (2004) Differential effects on human immunodeficiency virus Type 1 replication by α-defensins with comparable bactericidal activities. J Virol 78: 11622-11631.
24. Cedillo-Rivera R, Munoz O, (1992) In vitro susceptibility of Ginrdia intestinalis to albendazole, mebendazole, and other chemotherapeutic agents. J Med Microbiol 37: 221-226.
25. Hancock REW, Wong PGW, (1984) Compounds which increase the permeability of Pseudomanas aeruginosa outer membrane. Antimicrob Agents Chemother 26: 48-52.
26. Mejia-Alvarej R, Kettlun C, Rios E, Stern M, Fill M, (1999) Unitary Ca2+ current through cardiac ryanodine receptor channels under quasi-physiological ionic conditions. J Gen Physiology 113: 177-186.
27. Rishi P, Preet S, Bharrhan S, Verma I, (2011) In vitro and in vivo synergy of cryptdin-2 and ampicillin against Salmonella. Antimicrob Agents Chemother 55: 4176-4182.
28. De Beer, Edwin J, Johnston CG, Wilson DW, (1935) The composition of intestinal secretions. J Biol Chem 108: 113.
29. Sladen GE, (1971) Conservation of fluid and electrolytes by the human gut. J Clin Path 24: 99-107.
30. Nuding S, Fellermann K, Wehkamp J, Mueller HA, Stange EF, (2006) A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J Microbiol Meth 65: 335-345.
31. Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R, (1999) SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463: 58-62.
32. Richards RC, O'Neil DB, Thibault P, Ewart KV, (2001) Histone H1: an antimicrobial protein of Atlantic salmon (Salmo salar). Biochem Biophys Res Commun 284: 549-555.
33. Sitaram N, Sai KP, Singh S, Sankaran K, Nagaraj R, (2002) Structure-function relationship studies on the frog skin antimicrobial peptide tigerinin 1: design of analogs with improved activity and their action on clinical bacterial isolates. Antimicrob Agents Chemother 46: 2279-2283.
34. Shimoda M, Ohki K, Shimamoto Y, Kohashi O, (1995) Morphology of defensin treated Staphylococcus aureus. Infect Immun 63: 2886-2891.
35. Subbalakshmi C, Krishnakumari V, Nagaraj R, Sitaram N, (1996) Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett 395: 48-52.
36. Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, et al. (2001) Antibacterial agents based on the cyclic D, L-alpha-peptide architecture. Nature 412: 452-455.
37. Matsuzaki K, (1999) Why and how are peptide-lipid interactions utilized for self-defense? magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462: 1-10.
38. Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB, et al. (2002) Lentivirus lytic peptide- 1 perturbs both outer and inner membranes of Serratia marcescens. Antimicrobial Agents Chemother 46: 2041-2045.
39. Lencer WI, Cheung G, Strohmeier GR, Currie MG, Ouellette AJ, et al. (1997) Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci USA 94: 8585-8589.
40. Park CB, Kim HS, Kim SC, (1998) Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Bioph Res Comm 244: 253-257.
41. Skerlavaj B, Romeo D, Gennaro R, (1990) Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect Immun 58: 3724-3730.
42. Sharma S, Khuller G, (2001) DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra. Curr Microbiol 43: 74-76.
43. Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RE, (2002) Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46: 605-614.
44. Yenugu S, Hamil KG, Radhakrishnan Y, French FS, Hall SH, (2004) The Androgen regulated epididymal sperm-binding protein, ESC42 is an antimicrobial Beta-defensin. Endocrinology 145: 3165-3173.